Related Experiment Video
Updated: Jun 1, 2025
Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria
Published on: July 6, 2013
Bacteria as Precision Tools for Cancer Therapy
Carmen Michán1, José Prados2, Juan-Luis Ramos3
1Departamento de Bioquímica y Biología Molecular, Campus de Excelencia Internacional Agroalimentario CeiA3, Universidad de Córdoba, Córdoba, Spain.
Abstract:
The discovery at the end of the 20th century of genes that induce cell death revolutionised the biocontaintment of genetically manipulated bacteria for environmental or agricultural applications. These bacterial 'killer' genes were then assayed for their potential to target and control malignant cells in human cancers. The identification of the bacteriomes in different human organs and tissues, coupled with the observation that bacteria tend to accumulate near tumours, has opened new avenues for anti-cancer strategies. This progress, along with recent insights into how cancer cells evade immune response, has prompted innovative therapeutic approaches. Tumour microenvironments are typically nutrient-rich, characterised by low oxygen tensions and very resistant to immune responses. Two recent studies in MBT highlight the promise of using Salmonella typhimurium and Escherichia coli as vectors in novel cancer treatments. Engineered S. typhimurium strains can generate adjuvant flagellin-antigen complexes that function as in situ vaccines, hence increasing the immunogenic responses within tumour environment. Similarly, gut E. coli can be used as vectors to targert tumour cells in colon cancer, enabling both diagnostic applications and localised treatments. Both approaches hold significant potential to improve patient survival outcomes.
Insights
Genetically engineered bacteria, like Salmonella typhimurium and Escherichia coli, show promise as cancer treatments. These microbes can target tumors, stimulate immune responses, and offer new therapeutic avenues for improved patient survival.
Area of Science:
- Microbiology
- Oncology
- Biotechnology
Background:
- Discovery of cell-death-inducing genes revolutionized biocontainment of genetically modified bacteria.
- Bacteria accumulate near tumors, presenting opportunities for novel anti-cancer strategies.
- Understanding tumor microenvironments and immune evasion is crucial for therapeutic innovation.
Purpose of the Study:
- To explore the potential of genetically engineered bacteria as anti-cancer agents.
- To investigate novel therapeutic approaches utilizing bacterial vectors for cancer treatment.
- To highlight recent advancements in bacterial-based cancer therapy.
Main Methods:
- Engineering Salmonella typhimurium to produce in situ vaccines (flagellin-antigen complexes).
- Utilizing gut Escherichia coli as vectors for targeted colon cancer treatment and diagnostics.
- Assaying bacterial 'killer' genes for their efficacy against malignant cells.
Main Results:
- Engineered S. typhimurium enhances immunogenic responses within the tumor microenvironment.
- Engineered E. coli demonstrates potential for targeted colon cancer therapy and diagnostics.
- Bacterial vectors show promise in overcoming tumor resistance and improving anti-cancer efficacy.
Conclusions:
- Genetically engineered bacteria offer innovative strategies for cancer treatment.
- Bacterial-based therapies, including in situ vaccination and targeted delivery, hold significant potential.
- These approaches may lead to improved patient survival outcomes in cancer therapy.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
00:57Antibiotic Selection
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...